384 related articles for article (PubMed ID: 18055762)
21. Interaction of barbiturate analogs with the Torpedo californica nicotinic acetylcholine receptor ion channel.
Arias HR; McCardy EA; Gallagher MJ; Blanton MP
Mol Pharmacol; 2001 Sep; 60(3):497-506. PubMed ID: 11502880
[TBL] [Abstract][Full Text] [Related]
22. Quinacrine noncompetitive inhibitor binding site localized on the Torpedo acetylcholine receptor in the open state.
Johnson DA; Ayres S
Biochemistry; 1996 May; 35(20):6330-6. PubMed ID: 8639577
[TBL] [Abstract][Full Text] [Related]
23. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
Arias HR
Arch Biochem Biophys; 1999 Nov; 371(1):89-97. PubMed ID: 10525293
[TBL] [Abstract][Full Text] [Related]
24. Desensitization of the nicotinic acetylcholine receptor mainly involves a structural change in solvent-accessible regions of the polypeptide backbone.
Baenziger JE; Chew JP
Biochemistry; 1997 Mar; 36(12):3617-24. PubMed ID: 9132013
[TBL] [Abstract][Full Text] [Related]
25. Identification of nicotinic acetylcholine receptor amino acids photolabeled by the volatile anesthetic halothane.
Chiara DC; Dangott LJ; Eckenhoff RG; Cohen JB
Biochemistry; 2003 Nov; 42(46):13457-67. PubMed ID: 14621991
[TBL] [Abstract][Full Text] [Related]
26. Noncompetitive inhibitors reach their binding site in the acetylcholine receptor by two different paths.
Blanton M; McCardy E; Gallaher T; Wang HH
Mol Pharmacol; 1988 Jun; 33(6):634-42. PubMed ID: 3380079
[TBL] [Abstract][Full Text] [Related]
27. Agonist binding and affinity state transitions in reconstituted nicotinic acetylcholine receptors revealed by single and sequential mixing stopped-flow fluorescence spectroscopies.
Raines DE; Krishnan NS
Biochim Biophys Acta; 1998 Sep; 1374(1-2):83-93. PubMed ID: 9814855
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors.
Arias HR; Bhumireddy P; Spitzmaul G; Trudell JR; Bouzat C
Biochemistry; 2006 Feb; 45(7):2014-26. PubMed ID: 16475790
[TBL] [Abstract][Full Text] [Related]
29. Intramembrane aromatic interactions influence the lipid sensitivities of pentameric ligand-gated ion channels.
Carswell CL; Sun J; Baenziger JE
J Biol Chem; 2015 Jan; 290(4):2496-507. PubMed ID: 25519904
[TBL] [Abstract][Full Text] [Related]
30. Molecular sites of general anaesthetic action on acetylcholine receptors.
Tonner PH; Miller KW
Eur J Anaesthesiol; 1995 Jan; 12(1):21-30. PubMed ID: 7535690
[TBL] [Abstract][Full Text] [Related]
31. Photoaffinity labeling the torpedo nicotinic acetylcholine receptor with [(3)H]tetracaine, a nondesensitizing noncompetitive antagonist.
Middleton RE; Strnad NP; Cohen JB
Mol Pharmacol; 1999 Aug; 56(2):290-9. PubMed ID: 10419547
[TBL] [Abstract][Full Text] [Related]
32. Molecular dynamics simulations of ternary membrane mixture: phosphatidylcholine, phosphatidic acid, and cholesterol.
Cheng MH; Liu LT; Saladino AC; Xu Y; Tang P
J Phys Chem B; 2007 Dec; 111(51):14186-92. PubMed ID: 18052271
[TBL] [Abstract][Full Text] [Related]
33. Elucidation of biphasic alterations on acetylcholinesterase (AChE) activity and membrane fluidity in the structure-functional effects of tetracaine on AChE-associated membrane vesicles.
Chen CH; Zuklie BM; Roth LG
Arch Biochem Biophys; 1998 Mar; 351(1):135-40. PubMed ID: 9500847
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors.
Arias HR; Bhumireddy P; Bouzat C
Int J Biochem Cell Biol; 2006; 38(8):1254-76. PubMed ID: 16520081
[TBL] [Abstract][Full Text] [Related]
35. Probing the structure of the affinity-purified and lipid-reconstituted torpedo nicotinic acetylcholine receptor.
Hamouda AK; Chiara DC; Blanton MP; Cohen JB
Biochemistry; 2008 Dec; 47(48):12787-94. PubMed ID: 18991407
[TBL] [Abstract][Full Text] [Related]
36. Identification of amino acids of the torpedo nicotinic acetylcholine receptor contributing to the binding site for the noncompetitive antagonist [(3)H]tetracaine.
Gallagher MJ; Cohen JB
Mol Pharmacol; 1999 Aug; 56(2):300-7. PubMed ID: 10419548
[TBL] [Abstract][Full Text] [Related]
37. Noncompetitive antagonist binding sites in the torpedo nicotinic acetylcholine receptor ion channel. Structure-activity relationship studies using adamantane derivatives.
Arias HR; Trudell JR; Bayer EZ; Hester B; McCardy EA; Blanton MP
Biochemistry; 2003 Jun; 42(24):7358-70. PubMed ID: 12809491
[TBL] [Abstract][Full Text] [Related]
38. Effect of calcium and phosphatidic acid binding on the C2 domain of PKC alpha as studied by Fourier transform infrared spectroscopy.
García-García J; Corbalán-García S; Gómez-Fernández JC
Biochemistry; 1999 Jul; 38(30):9667-75. PubMed ID: 10423245
[TBL] [Abstract][Full Text] [Related]
39. Agonist-induced displacement of quinacrine from its binding site on the nicotinic acetylcholine receptor: plausible agonist membrane partitioning mechanism.
Arias HR
Mol Membr Biol; 1995; 12(4):339-47. PubMed ID: 8747279
[TBL] [Abstract][Full Text] [Related]
40. Modulation of nicotinic acetylcholine receptor function through the outer and middle rings of transmembrane domains.
Barrantes FJ
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):620-32. PubMed ID: 14579511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
